UCB
CIMZIA
Manufacturer:
UCB
Name:
CIMZIA
HCPCS Code Descriptor:
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Category:
J Code
HCPCS:
J0717
NDC(s):
50474-0710-81, 50474-0710-79, 50474-0700-62
Primary Type:
Immunology:Anti-TNF
Generic/Specialty Status:
Single-Source
Route of Administration:
Subcutaneous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
CIMZIA is an Immunology:Anti-TNF drug manufactured by UCB and administered via the Subcutaneous route of administration. The J Code: J0717 is aligned to the drug CIMZIA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/14
HCPCS Effective Date:
1/1/14
HCPCS Short Description:
Certolizumab pegol inj 1mg
Billing and Coding Guide:
https://www.cimziainoffice.com/sites/default/files/2023-01/US-P-CZ-AS-2200281_FRE_CZP_Process_Guide_Digital_121222.pdf
Patient Assistance:
https://www.ucb-usa.com/Patients/Patients